[email protected] The major goal of my research is to study the pancreatic cancer (PC) pathogenesis and develop new therapies. Current projects include the role of zinc transporter ZIP4 in PC, the therapeutic potential for ZIP4 shRNA-based treatment, the function of microRNAs in ZIP4-mediated PC growth, signaling transduction and metabolism in ...

Dr. Min Li is George Lynn Cross Research Professor of Medicine, Surgery, and Cell Biology at The University of Oklahoma Health Sciences Center (OUHSC), and holds the Virginia Kerley Cade Endowed Chair in Cancer Treatment.

2020年6月1日 · Identifying Mental Health Literacy as a Key Predictor of COVID-19 Vaccination Acceptance among American Indian/Alaska Native/Native American People. Vaccines (Basel). 2023 Nov 30; 11 (12). PMID: 38140196; PMCID: PMC10748283. Li M, Schwab M. A journey to excellence: Disseminating groundbreaking discoveries in oncology research.

2024年11月22日 · Min Li, Ph.D., a George Lynn Cross Professor of Medicine, Surgery and Cell Biology at the University of Oklahoma College of Medicine and Associate Director for Global Oncology at OU Health Stephenson Cancer Center, will receive the 2024 Palade Prize from the International Association of Pancreatology.

Complement-containing small extracellular vesicles from adventitial fibroblasts induce proinflammatory and metabolic reprogramming in macrophages.

From my early work on comparing concept-mapping techniques to more recent work on analyzing the large-scale test items (like TIMSS), I focus on exploring assessment tools that tap into different cognitive factors. My work is mainly geared towards tying the science of cognition to the research of assessment.

2024年12月1日 · Min Li a George Lynn Cross Professor of Medicine, Surgery, and Cell Biology at the University of Oklahoma College of Medicine and Associate Director for Global Oncology at OU Health Stephenson Cancer Center, has been awarded the 2024 Palade Prize by the International Association of Pancreatology.

We study molecular mechanisms and pathways that underlie neurodegeneration. Our goal is to develop therapeutic agents with potential to treat Alzheimer's disease and other neurodegenerative diseases.

Our current research is focused on biochemical and structural study of HIV-1 integration, especially on the indispensable intermediates, a series of stable nucleoprotein complexes of …